Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 69,126 shares of common stock, with an aggregate market value of approximately $711,615, on 11/14/2024. The shares to be sold were acquired through restricted stock vesting on various dates including 08/01/2024, 08/17/2024, 08/18/2024, and 11/01/2024, with additional shares acquired via stock option exercise on 01/12/2024. The securities were obtained directly from Arcutis Biotherapeutics. In the past three months, Burnett has sold a total of 17,169 shares, generating gross proceeds of $147,892.

Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 69,126 shares of common stock, with an aggregate market value of approximately $711,615, on 11/14/2024. The shares to be sold were acquired through restricted stock vesting on various dates including 08/01/2024, 08/17/2024, 08/18/2024, and 11/01/2024, with additional shares acquired via stock option exercise on 01/12/2024. The securities were obtained directly from Arcutis Biotherapeutics. In the past three months, Burnett has sold a total of 17,169 shares, generating gross proceeds of $147,892.